Abrdn Healthcare Investors Stock
Abrdn Healthcare Investors
Company data
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
- CEO
- Daniel R. Omstead
- Market cap
- $1.1 B
- IPO
- 23/04/1987
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The company is headquartered in Philadelphia, United States, and is listed on the NYSE. The fund invests in public equity markets across the globe with a specific focus on the healthcare sector. Its investment strategy…
Company description based on the data provider's company data, AI-assisted, created on 17/10/2026. Not investment advice.
Abrdn Healthcare Investors stock: price history
1D
-1.7%
1W
-4.8%
1M
-11.0%
6M
-5.0%
YTD
+0.2%
1Y
-0.3%
2Y
+1.3%
5Y
-26.5%
10Y
-13.6%
Abrdn Healthcare Investors stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 18/09/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
Abrdn Healthcare Investors is a closed-end equity fund managed by abrdn Inc. The fund invests globally in healthcare sector companies, particularly in biotechnology, medical devices, and pharmaceuticals. A focus is placed on small-cap growth equities. The investment strategy employs fundamental analysis with emphasis on market positions, management quality, technological expertise, and the financing capabilities of target companies. The fund is benchmarked against indices such as the NASDAQ Biotechnology Index or the S&P 500 Healthcare Index.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Network effects
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Abrdn Healthcare Investors
Abrdn Healthcare Investors stock metrics
P/E
10.32
P/B
0.93
EV/EBITDA
11.01
RETURN ON EQUITY
15.9%
NET MARGIN
1,018.5%
DEBT/EQUITY
0
DIVIDEND YIELD
13.0%
AS OF
30/09/2025
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
57,191,685
AVG. DAILY VOLUME (30D)
174,901
Insider transactions (SEC)
Goodson Alan R
Mahai Chris LaVictoire
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Abrdn Healthcare Investors stock
What does Abrdn Healthcare Investors do?
Abrdn Healthcare Investors is a company in the Financial Services sector, Asset Management industry, headquartered in United States.
The IPO was on 23/04/1987; the stock trades on NYSE under the ticker HQH.
Does Abrdn Healthcare Investors pay a dividend?
Yes. The last dividend was US$0.66 per share, ex-date 24/08/2026, paid on 30/09/2026.
The dividend yield is 13.0% (as of 30/09/2025).
Which stocks are comparable to Abrdn Healthcare Investors?
Comparable stocks include BlackRock, Blackstone, KKR &, Apollo Global Management, State Street, Ameriprise Financial, Ares Management and Northern Trust.
How can I get Abrdn Healthcare Investors stock analyzed?
Clicking "Analyze stock" lets five strategies assess Abrdn Healthcare Investors against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.